HealthEquity, Inc. (HQY) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $83.67. It has a SharesGrow Score of 76/100, indicating a strong investment profile with 5 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of HQY = $932.43 (+1014.4% from the current price, the stock appears undervalued). Analyst consensus target is HQY = $108 (+28.7% upside).
Valuation: HQY trades at a trailing Price-to-Earnings (P/E) of 33.4 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 2.16.
Financials: revenue is $1.3B, +15.2%/yr average growth. Net income is $215M, growing at +169.7%/yr. Net profit margin is 16.4% (healthy). Gross margin is 69.5% (+12.6 pp trend).
Balance sheet: total debt is $1.0B against $2.1B equity (Debt-to-Equity (D/E) ratio 0.48, conservative). Current ratio is 3.27 (strong liquidity). Debt-to-assets is 29.2%. Total assets: $3.4B.
Analyst outlook: 25 / 27 analysts rate HQY as buy (93%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 45/100 (Partial), Growth 90/100 (Pass), Past 75/100 (Partial), Health 83/100 (Pass), Moat 74/100 (Pass), Future 94/100 (Pass), Income 70/100 (Pass).
